Bank of New York Mellon’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.2M Buy
1,682,837
+73,141
+5% +$1.23M 0.01% 1331
2025
Q1
$24.7M Sell
1,609,696
-11,648
-0.7% -$179K ﹤0.01% 1385
2024
Q4
$35.7M Buy
1,621,344
+67,571
+4% +$1.49M 0.01% 1227
2024
Q3
$28M Sell
1,553,773
-48,440
-3% -$873K 0.01% 1382
2024
Q2
$26M Sell
1,602,213
-33,055
-2% -$537K ﹤0.01% 1425
2024
Q1
$23.1M Sell
1,635,268
-229,607
-12% -$3.24M ﹤0.01% 1493
2023
Q4
$19.5M Sell
1,864,875
-37,360
-2% -$390K ﹤0.01% 1607
2023
Q3
$19.4M Buy
1,902,235
+19,906
+1% +$203K ﹤0.01% 1558
2023
Q2
$14.2M Buy
1,882,329
+76,961
+4% +$580K ﹤0.01% 1756
2023
Q1
$16M Sell
1,805,368
-60,399
-3% -$535K ﹤0.01% 1672
2022
Q4
$17M Buy
1,865,767
+9,834
+0.5% +$89.7K ﹤0.01% 1622
2022
Q3
$15M Buy
1,855,933
+14,876
+0.8% +$120K ﹤0.01% 1666
2022
Q2
$13.8M Sell
1,841,057
-34,337
-2% -$258K ﹤0.01% 1749
2022
Q1
$17.6M Buy
1,875,394
+28,920
+2% +$272K ﹤0.01% 1746
2021
Q4
$14.8M Buy
1,846,474
+53,274
+3% +$427K ﹤0.01% 1894
2021
Q3
$17.5M Buy
1,793,200
+32,617
+2% +$318K ﹤0.01% 1800
2021
Q2
$17.4M Sell
1,760,583
-182,087
-9% -$1.8M ﹤0.01% 1809
2021
Q1
$22.4M Sell
1,942,670
-55,257
-3% -$638K ﹤0.01% 1645
2020
Q4
$19.3M Sell
1,997,927
-16,700
-0.8% -$161K ﹤0.01% 1659
2020
Q3
$18.2M Sell
2,014,627
-2,566
-0.1% -$23.1K ﹤0.01% 1536
2020
Q2
$24.9M Buy
2,017,193
+125,519
+7% +$1.55M 0.01% 1307
2020
Q1
$17M Sell
1,891,674
-31,334
-2% -$281K 0.01% 1398
2019
Q4
$18.8M Sell
1,923,008
-63,544
-3% -$623K ﹤0.01% 1608
2019
Q3
$13.7M Buy
1,986,552
+30,732
+2% +$211K ﹤0.01% 1754
2019
Q2
$18.1M Buy
1,955,820
+127,204
+7% +$1.17M ﹤0.01% 1620
2019
Q1
$28.7M Sell
1,828,616
-146,422
-7% -$2.3M 0.01% 1324
2018
Q4
$30.5M Buy
1,975,038
+67,168
+4% +$1.04M 0.01% 1204
2018
Q3
$41.1M Sell
1,907,870
-41,730
-2% -$899K 0.01% 1157
2018
Q2
$47.4M Buy
1,949,600
+4,763
+0.2% +$116K 0.01% 1049
2018
Q1
$33.2M Sell
1,944,837
-156,817
-7% -$2.68M 0.01% 1238
2017
Q4
$39.8M Sell
2,101,654
-12,818,671
-86% -$243M 0.01% 1137
2017
Q3
$263M Sell
14,920,325
-3,314,205
-18% -$58.3M 0.07% 288
2017
Q2
$606M Sell
18,234,530
-1,163,875
-6% -$38.7M 0.17% 118
2017
Q1
$622M Sell
19,398,405
-316,909
-2% -$10.2M 0.17% 118
2016
Q4
$715M Buy
19,715,314
+3,590,348
+22% +$130M 0.21% 99
2016
Q3
$742M Buy
16,124,966
+1,256,324
+8% +$57.8M 0.22% 88
2016
Q2
$747M Buy
14,868,642
+1,972,944
+15% +$99.1M 0.23% 89
2016
Q1
$690M Buy
12,895,698
+3,756,401
+41% +$201M 0.21% 104
2015
Q4
$600M Buy
9,139,297
+2,310,846
+34% +$152M 0.18% 116
2015
Q3
$386M Buy
6,828,451
+1,604,114
+31% +$90.6M 0.12% 171
2015
Q2
$309M Sell
5,224,337
-476,936
-8% -$28.2M 0.09% 248
2015
Q1
$355M Buy
5,701,273
+434,246
+8% +$27.1M 0.09% 233
2014
Q4
$303M Sell
5,267,027
-443,217
-8% -$25.5M 0.08% 276
2014
Q3
$307M Sell
5,710,244
-2,499,722
-30% -$134M 0.08% 260
2014
Q2
$430M Sell
8,209,966
-131,510
-2% -$6.89M 0.12% 182
2014
Q1
$441M Sell
8,341,476
-336,824
-4% -$17.8M 0.12% 171
2013
Q4
$348M Buy
8,678,300
+3,220,731
+59% +$129M 0.1% 214
2013
Q3
$206M Buy
5,457,569
+143,447
+3% +$5.42M 0.06% 332
2013
Q2
$208M Buy
+5,314,122
New +$208M 0.07% 312